XML 38 R22.htm IDEA: XBRL DOCUMENT

Derivatives

12 Months Ended

Dec. 31, 2024

Derivatives

16. Derivatives

The Company conducts a large portion of its operations in international markets which subject it to foreign currency fluctuations. The most significant foreign currency exposures occur when revenue and associated accounts receivable are collected in one currency and expenses to generate revenues are incurred in another currency. The Company is also subject to wage inflation and other government mandated increases and operating expenses in Asian countries where the Company has the majority of its operations. The Company’s primary inflation and exchange rate exposure relates to payroll, other payroll costs and operating expenses in the Philippines, India, Sri Lanka and Israel.

In addition, although most of the Company’s revenue is denominated in U.S. dollars, a significant portion of total revenues is denominated in Canadian dollars, Pound Sterling and Euros.

The Company’s policy is to enter derivative instrument contracts with terms that coincide with the underlying exposure being hedged for a period up to 12 months. As such, the Company’s derivative instruments are expected to be highly effective. For derivative instruments that are designated and qualify as cash flow hedges, the entire change in fair value of the hedging instrument is recorded to Other comprehensive income (loss). Upon settlement of these contracts, the change in the fair value recorded in Other comprehensive income (loss) are reclassified to earnings and included as part of Direct operating costs. For derivative instruments that are not designated as hedges, any change in fair value is recorded directly in earnings as part of Direct operating costs.

The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking hedge transactions. The Company does not hold or issue derivatives for trading purposes. All derivatives are recognized at their fair value and classified based on the instrument’s maturity date. The total notional amount for outstanding derivatives designated as hedges was $22.5 million and $10.5 million as of December 31, 2024 and 2023, respectively.

The following table presents the fair value of derivative instruments included within the consolidated balance sheets as of December 31, 2024 and 2023 (in thousands):


		Balance Sheet Location		Fair Value
				2024			2023
Derivatives designated as hedging instruments:
Foreign currency forward contracts		Accrued expenses		$	499		$	-
Foreign currency forward contracts		Prepaid expenses and other current assets		$	-		$	41

The effect of foreign currency forward contracts designated as cash flow hedges on the consolidated statements of operations for the years ended December 31, 2024 and 2023 were as follows (in thousands):


		2024			2023
Net gain (loss) recognized in OCI⁽¹⁾		$	(494)		$	185
Net loss reclassified from accumulated OCI into income⁽²⁾		$	(58)		$	(221)
Net gain recognized in income⁽³⁾		$	-		$	-

(1)	Net change in fair value of the effective portion classified into other comprehensive income (“OCI”)

(2)	Effective portion classified within direct operating costs.

(3)	There were no ineffective portions for the period presented.